Results 251 to 260 of about 53,470 (300)

Economic Evaluation of Bruton's Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukaemia in South Africa. [PDF]

Appl Health Econ Health Policy
Woudberg R, Sinanovic E.
europepmc   +1 more source

Cost-Effectiveness of an Absorbable Antibacterial Envelope for Infection Control in Cardiac Implantable Electronic Device Procedures in Spain. [PDF]

J Health Econ Outcomes Res
Datino T, Afonso D, Greaves E, Eggington S, Monge J, Álvarez Orozco M, Wolff C, Mealing S, de Alarcón A.   +8 more
europepmc   +1 more source

Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer. [PDF]

Breast Cancer Res Treat
Chiddarwar T, Blaes A, Kuntz K.
europepmc   +1 more source

The relative societal value of health gains to different beneficiaries [PDF]

Dolan, P., Edlin, R., Tsuchiya, A.
core  

Modeled Health and Economic Burden of Frailty and Falls Among Adults With HIV.

JAMA Netw Open
Smith KC, Brown C, Hyle EP, Zafarnejad R, Brown TT, Freedberg KA, Erlandson KM, Losina E.   +7 more
europepmc   +1 more source

Cost-Effectiveness of Early vs Delayed Belimumab Treatment for Systemic Lupus Erythematosus.

JAMA Netw Open
Hundal S, Cappelli J, Sjöwall C, Osman M, Touma Z, Parodis I, Goldberg SR, Netchiporouk E.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

QALYs and justice

Health Policy, 1989
Health Policy, 10 (1988) 259-266 featured an article by Harris which argued that QALYs (quality-adjusted life years) are unjust, and that their use as a tool for distributing scarce health resources cannot be morally defended. Harris' paper is the latest in a series of articles purporting to criticise the concept and application of QALYs. However, most
Ichiro Kawachi
exaly   +3 more sources

Multiattribute Structure for QALYs

Decision Analysis, 2004
Health status is inherently a multiattribute construct. We examine multiattribute utility decompositions for the quality-adjusted life year (QALY) utility model commonly employed in medical decision and cost-effectiveness analyses. We consider several independence conditions on preference, including the classical notions of preferential independence ...
Gordon B Hazen
exaly   +2 more sources